{
    "title": "Merck raises 2022 forecast as COVID pill, cancer drug fuels profit beat",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10763195/Merck-profit-tops-expectations-demand-COVID-pill-cancer-drugs.html",
    "date": "2022-04-28",
    "keywords": [
        "revenue",
        "share",
        "profit",
        "demand",
        "cancer",
        "drug",
        "pill",
        "molnupiravir",
        "quarter",
        "analyst",
        "reporting",
        "erman",
        "co",
        "thursday",
        "vaccine",
        "opening",
        "bell",
        "growth",
        "company",
        "cut",
        "end",
        "range",
        "capacity",
        "market",
        "officer",
        "caroline",
        "data",
        "conference",
        "call",
        "acquisition",
        "loss",
        "exclusivity",
        "intelligence",
        "immunotherapy",
        "keytruda",
        "gardasil",
        "papillomavirus",
        "street",
        "merck",
        "enthusiasm",
        "ridgeback",
        "therapy",
        "pfizer",
        "inc",
        "estimate",
        "drugmaker",
        "forecast",
        "view",
        "bill",
        "berkrot",
        "koyyur",
        "alexandra",
        "hudson"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}